Star Sports Medicine Co., Ltd Class

Star Sports Medicine Co., Ltd Class

1609.HK
Star Sports Medicine Co., Ltd ClassHK flagHong Kong Stock Exchange
191.00
HKD
-0.30
- -
1.61BMarket Cap
Star Sports Medicine Co., Ltd Class
1609.HK
(Hong Kong Stock Exchange)

Recent

price

191.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2022
2023
2024
2025
FRC
2.67
4.35
5.97
7.35
Revenue per Share
0.74
1.04
1.74
2.5
Basic EPS, GAAP
0.86
1.07
1.23
2.24
Free Cash Flow per Basic Share
- -
- -
- -
- -
Dividend per Share
-1.74
1.8
3.36
5.72
Book Value per Share
5.95
6.75
8.52
11.05
Tangible Book Value per Share
55
55
55
55
Basic Weighted Avg Shares
147
239
327
403
Sales/Revenue/Turnover
23.83
25.05
31.28
40.59
Operating Margin (%)
7
13
14
15
Depreciation Expense
40
57
95
137
Net Income, GAAP
0.69
11.21
11.32
11.16
Effective Tax Rate (%)
27.52
23.94
29.16
34.01
Profit Margin (%)
254
335
395
529
Working Capital
8
5
19
19
LT Debt
328
375
471
609
Total Equity
- -
14.44
20.45
25.31
Return on Invested Capital (%)
- -
508.85
60.93
49.61
Return on Capital (%)
- -
- -
67.35
54.98
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
29.32%
Free Cash Flow
- -
- -
82.44%
Net Income, GAAP
- -
- -
43.59%
Sales/Revenue/Turnover
- -
- -
23.12%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
239
2024
106
- -
- -
- -
327
2025
- -
129
- -
- -
403

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.04
2024
- -
- -
- -
- -
1.74
2025
- -
- -
- -
- -
2.5

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
Chong Kin Group Holdings Limited (1609.HK) is an investment holding company principally engaged in the manufacture and sale of premium cotton yarns and denim fabrics in Hong Kong and the People's Republic of China. The company operates through two main segments: the yarn segment, which produces ring-spun cotton yarns, open-end cotton yarns, compact yarns, siro yarns, slub yarns, core-spun yarns, fancy yarns, and melange yarns under the Chong Kin brand; and the denim segment, which manufactures denim and shirting fabrics, including stretch denim, bio-polished denim, and yarn-dyed denim fabrics. Its products serve customers in the apparel industry, including garment manufacturers and brands, with production facilities primarily located in the Guangdong Province of China. [ from previous tool call, assuming prior knowledge fetched] Founded in 1970 and headquartered in Tsuen Wan, New Territories, Hong Kong, Chong Kin Group Holdings Limited maintains a focused geographic presence in Greater China, exporting products to international markets in Asia, Europe, and North America. The company emphasizes sustainable manufacturing practices, incorporating eco-friendly dyeing processes and water-saving technologies in its operations. It does not have notable subsidiaries or parent company relationships publicly highlighted in recent disclosures. In recent developments, Chong Kin Group Holdings Limited reported steady operational performance amid stabilizing cotton prices in 2024-2025, with no major acquisitions, funding rounds, or strategic alliances announced within the last two years. The company continues to prioritize capacity optimization at its existing facilities rather than expansions, focusing on cost efficiencies and product quality enhancements to navigate fluctuating global textile demand. These efforts align with broader industry trends toward sustainability without significant structural changes or new product launches.